Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,003 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Structural analysis of the GPI glycan.
Nakano M, Sabido-Bozo S, Okazaki K, Aguilera-Romero A, Rodriguez-Gallardo S, Cortes-Gomez A, Lopez S, Ikeda A, Funato K, Muñiz M. Nakano M, et al. Among authors: okazaki k. PLoS One. 2021 Sep 16;16(9):e0257435. doi: 10.1371/journal.pone.0257435. eCollection 2021. PLoS One. 2021. PMID: 34529709 Free PMC article.
Quality-controlled ceramide-based GPI-anchored protein sorting into selective ER exit sites.
Rodriguez-Gallardo S, Sabido-Bozo S, Ikeda A, Araki M, Okazaki K, Nakano M, Aguilera-Romero A, Cortes-Gomez A, Lopez S, Waga M, Nakano A, Kurokawa K, Muñiz M, Funato K. Rodriguez-Gallardo S, et al. Among authors: okazaki k. Cell Rep. 2022 May 3;39(5):110768. doi: 10.1016/j.celrep.2022.110768. Cell Rep. 2022. PMID: 35508142 Free article.
Clinical profile of IgG4-related disease in Japan based on the rare disease data registry.
Yamamoto M, Kanda M, Mizushima I, Kanno A, Umemura T, Ikeura T, Kodama Y, Dobashi H, Tanaka Y, Masamune A, Moriyama M, Saeki T, Matsui S, Origuchi T, Masaki Y, Asada M, Umehara H, Seno H, Naitoh I, Yamamoto S, Iwasaki E, Kubota K, Tanoue S, Nishino T, Tsuboi H, Matsumoto Y, Isayama H, Goto H, Notohara K, Uchida K, Kawabe K, Yamada K, Kasashima S, Takahira M, Sato Y, Kawachi I, Yamaguchi I, Okazaki K, Nakamura S, Matsuda F, Ishikawa H, Kawano M; Patient Registry Committee, Research Program for Intractable Disease by the Ministry of Health, Labour and Welfare (MHLW), Japan; *Other than the co-authors, the members of Patient Registry Committee, Research Program for Intractable Disease by the Ministry of Health, Labour and Welfare (MHLW), Japan are as follows: Kensuke Yokoyama (Jichi Medical University);. Yamamoto M, et al. Among authors: okazaki k. Immunol Med. 2024 Nov 28:1-11. doi: 10.1080/25785826.2024.2430812. Online ahead of print. Immunol Med. 2024. PMID: 39607031 Free article.
Inebilizumab for Treatment of IgG4-Related Disease.
Stone JH, Khosroshahi A, Zhang W, Della Torre E, Okazaki K, Tanaka Y, Löhr JM, Schleinitz N, Dong L, Umehara H, Lanzillotta M, Wallace ZS, Ebbo M, Webster GJ, Martinez Valle F, Nayar MK, Perugino CA, Rebours V, Dong X, Wu Y, Li Q, Rampal N, Cimbora D, Culver EL; MITIGATE Trial Investigators. Stone JH, et al. Among authors: okazaki k. N Engl J Med. 2024 Nov 14. doi: 10.1056/NEJMoa2409712. Online ahead of print. N Engl J Med. 2024. PMID: 39541094
2,003 results